Zambon SA
20.8 FTEZambon reported revenue of €18.8m for the 2025 financial year (annual accounts filed with the NBB on 07 May 2026), with 20.8 full-time equivalents.
The score of Zambon shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +8 % Equity 0 % Total assets +15 % Headcount (avg FTE) -20 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Zambon's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 07 May 2026
- Year ended 31 Dec 2024filed on 17 Jun 2025
- Year ended 31 Dec 2023filed on 30 Apr 2024
- Year ended 31 Dec 2022filed on 20 Apr 2023
- Year ended 31 Dec 2021filed on 25 Apr 2022
Zambon's financial analysis
- Solvency38.5%sector median: 32.3%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Zambon
Zambon's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0403.069.741
- VAT number
- BE0403069741
- Peppol
- Registered · 0208:0403069741 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 19 Jul 1965
- Registered office
- 1090 Jette
- Size
- Small · 20.8 FTE
- Latest accounts
- 2025 · filed on 07 May 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Zambon (SA) has been based in Jette since 1965, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €18.8m, a net profit of €1.45m and equity of €2.96m. With 20.8 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 38.5%, above the median of its sector (32.3%).
Companies similar to Zambon
Companies in the same business, of comparable size and area, outside its group.
- P&G Health Belgium Wholesale of pharmaceutical and medical goods Grimbergen · balance sheet €20.8m
- EG Wholesale of pharmaceutical and medical goods Brussels · balance sheet €113.6m
- Philips Belgium Commercial Wholesale of pharmaceutical and medical goods Jette · balance sheet €33.0m
- BIOCODEX Benelux Wholesale of pharmaceutical and medical goods Forest · balance sheet €8.15m
- Norgine Wholesale of pharmaceutical and medical goods Leuven · balance sheet €14.1m
- Vétoquinol Wholesale of pharmaceutical and medical goods Niel · balance sheet €5.15m
- Exphar Wholesale of pharmaceutical and medical goods Nivelles · balance sheet €14.1m
- Guerbet Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €3.45m
Frequently asked questions about Zambon
What is the revenue of Zambon?
According to the 2025 annual accounts filed with the NBB, the revenue of Zambon amounts to 18,820,434 €.
What is the VAT number of Zambon?
In Belgium, the VAT number is the company number prefixed with BE: BE0403069741 for Zambon, if the company is VAT-registered. Its company number (CBE) is 0403.069.741.
Where is the registered office of Zambon?
According to the CBE register, the registered office of Zambon is in 1090 Jette.
What is the equity of Zambon?
At the close of the 2025 financial year, the equity of Zambon amounts to 2,955,078 €, a solvency of 38.5% of total assets.
How many people work at Zambon?
20.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Zambon?
The register lists 4 active mandates at Zambon. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Zambon
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →